(Adds details of vaccine, statement from WHO Africa director)
NAIROBI, Sept 13 (Reuters) - Kenya on Friday began adding a
malaria vaccine to its routine immunization schedule for babies
and toddlers, becoming the third African country to roll out the
vaccine for a disease that threatens children across the
continent.
Malaria, which kills one child globally every two minutes,
is the top killer of children under five in the east African
country. The vaccine - the world's first against malaria - will
be administered to children under two and could be crucial to
efforts to combat the disease, health officials said.
Other measures, such as nets to protect people from the
mosquitoes that carry the malaria parasite, have not proven
adequate to halt transmission, the director general of Kenya's
health ministry, Wekesa Masasabi, told Reuters.
"We still have an incidence of 27% (malaria infection) for
children under five," Masasabi said before Friday's launch of
the vaccine in the western county of Homa Bay.
The Homa Bay programme is the government's first step toward
creating awareness of the new vaccine, he said.
The injectable vaccine, called RTS,S or Mosquirix, was
developed by British drugmaker GlaxoSmithKline to
protect children from the most deadly form of malaria in Africa.
In clinical trials it proved only partially effective and it
needs to be given in a four-dose schedule, but it is the first
regulator-approved vaccine against the disease.
It has already been deployed in pilot programmes in Ghana
and Malawi.
Malaria infected about 219 million people in 2017 and killed
around 435,000. The vast majority of malaria deaths are among
babies and children in the poorest parts of Africa. Due to
ongoing transmission, half the world's population is still at
risk of contracting the disease.
The World Health Organization's regional director for
Africa, Matshidiso Moeti, said the Kenyan, Ghanaian and Malawian
pilots would provide key information and data for a future WHO
policy on broader use of the vaccine in sub-Saharan Africa.
A recent surge in malaria cases and deaths in the region is
threatening gains in the fight against the disease, she said,
adding that the vaccine "has the potential to save tens of
thousands of lives."
Kenya plans to roll out RTS,S to eight of its 47 counties
over the next two years, Masasabi said.
In a major report published last weekend, global health
experts said malaria could be eradicated within a generation
with the right tools, funding and political will.
Commissioned by The Lancet medical journal, the report
contradicted the conclusions last month of a malaria review by
the WHO. The experts urged the U.N. agency not to shy away from
this "goal of epic proportions".
(Reporting by Maggie Fick in Niarobi and Kate Kelland in London
Editing by Tom Hogue and Frances Kerry)
Glaxosmithkline (GSK)
